Dahham Alsoud
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Comparative Efficacy of IL-12/23 and IL-23 Inhibitors for Induction and Maintenance Therapy in Moderate-to-Severe Crohn's Disease: A Systematic Review and Network Meta-Analysis.
Journal: Inflammatory intestinal diseases
Published: June 02, 2025
Interleukin 12/23 and interleukin 23 inhibitors for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis.
Journal: Annals of gastroenterology
Published: May 29, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trials.
Journal: Journal of Crohn's & colitis
Published: April 28, 2025
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis.
Journal: Journal of Crohn's & colitis
Published: April 17, 2025
Mirikizumab for Ulcerative Colitis: A Game-Changer or Just Another Incremental Advance?
Journal: Digestive diseases and sciences
Published: March 17, 2025
Anti-IL 12/23 versus Anti-Tumor Necrosis Factor-α in Patients with Biologically Naïve Crohn's Disease: A Systematic Review and Meta-analysis.
Journal: Inflammatory intestinal diseases
Published: March 10, 2025
Assessment of PredictSURE IBD Assay in a Multinational Cohort of Patients With Inflammatory Bowel Disease.
Journal: United European gastroenterology journal
Published: February 02, 2025
Ustekinumab and Vedolizumab Exposure Is Unaffected by Pharmacogenetic Determinants of Anti-TNFs Pharmacokinetics.
Journal: Inflammatory bowel diseases
Published: April 06, 2024
Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
Journal: Inflammatory bowel diseases
Published: March 09, 2024
Calibration, Clinical Utility, and Specificity of Clinical Decision Support Tools in Inflammatory Bowel Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: January 23, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Journal: Therapeutic drug monitoring
Published: October 29, 2023
Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn's Disease: A Belgian Multicentric Cohort Study.
Journal: Inflammatory bowel diseases
Published: September 17, 2023
Last Updated: 09/26/2026